High throughput screening in calcium transient assay to assess cardiotoxicity of compounds using hiPSC-derived cardiomyocytes

Farbod Famili, Tsang WaiLam, Pieter van Loenen, Peter Nacken, Maaike Bras, Saman Honarnejad, Yang Jiang, Viola Borgdroff, Heribert Bohlen, Arie Reijerkerk, Helma Rutjes, Stefan Braam, Greg Luermanc
, Ncardia, Leiden, The Netherlands bPivot Park Screening Centre, Oss, The Netherlands cNcardia Inc., Plymouth Meeting, PA, United States of America Available online 17 October 2019.

Recent publications

Collaboration with CeMOS on cell based assay development and ultra-High Throughput Screening

Mass Spectrometry cell based assay development and ultra-High Throughput Screening

Virtual Screening for hit analogs

Accelerate progression of your hit series to leads through in-silico analysis

SARS-CoV-2

Ultra-High Throughput Hit Discovery against Protein-Protein interactions: A SAR CoV-2 Showcase

ultra-High Throughput Screening using Mass Spectrometry at Pivot Park Screening Centre

Target engagement assessment of drug-like and pan-assay interfering compounds using Affinity Selection Mass Spectrometry

Label-free Mass Spectrometry ultra-High Throughput Screening

Label-free Mass Spectrometry ultra-HighThroughput Screening

Customers & Partners

Can we help you to accelerate
your drug discovery?

Contact

+31 (0) 412 846050 info@ppscreeningcentre.com

Subscribe to our newsletter

Location

Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands

Shipping address

Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands

Disclaimer | Privacy Policy